We are analyzing https://link.springer.com/article/10.1186/s12935-021-02133-1.

Title:
Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway | Cancer Cell International
Description:
Background Epithelial–mesenchymal transition (EMT) promotes migration, invasion, and metastasis of hepatocellular carcinoma (HCC) cells. The molecular mechanisms behind EMT and metastasis in HCC remain unclear. Methods Microarray analysis was used to identify lncRNAs expression during polarization of U937 macrophages from M2 to M1 phenotype. The expression of the identified lncRNA was compared between clinical samples of HCC tissues or adjacent normal tissues, as well as between HCC and normal liver cell lines. lnc-Ma301 was overexpressed or knocked-down in HCC cell lines, and the effects were assessed in vitro and in vivo. Interactions among lnc-Ma301 and its potential downstream targets caprin-1 were investigated in HCC cell lines. Effects of lnc-Ma301 over- and underexpression on the Akt/Erk1 signaling pathways were examined. Results Microarray analyses identified lnc-Ma301 as one of the most overexpressed long non-coding RNAs during polarization of U937 macrophages from M2 to M1 phenotype. Lnc-Ma301 showed lower expression in HCC tissues than in adjacent normal tissues, and lower expression was associated with worse prognosis. Activation of lnc-Ma301 inhibited cell proliferation, migration and EMT in HCC cell cultures, and it inhibited lung metastasis of HCC tumors in mice. Mechanistic studies suggested that lnc-Ma301 interacts with caprin-1 to inhibit HCC metastasis and EMT through Akt/Erk1 pathway. Conclusions Lnc-Ma301 may help regulate onset and metastasis of HCC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

lncma, hcc, caprin, cell, expression, cells, fig, article, metastasis, google, scholar, tissues, cancer, proliferation, lncrnas, lung, hepatocellular, carcinoma, macrophages, cas, migration, tumor, rna, protein, usa, qrtpcr, data, emt, phenotype, proteins, analysis, normal, western, smmc, microarray, ecadherin, invasion, patients, performed, polarization, adjacent, blotting, lines, akt, china, erk, lncrna, mice, study, levels,

Topics {✒️}

pl-cmv-mcs-ef1-gfp + puro jian-hong zhong macrophage-derived t-ucr uc activating wnt/beta-catenin signaling biotin-conjugated anti-digoxin antibody le-qun li full-length lnc-ma301 showing lnc-ma301/caprin-1/akt/erk1 axis epithelial–mesenchymal transition epithelial-mesenchymal transition transcribe biotin-labelled rnas pl-lnc-ma301-smmc-7721 group pl-lnc-ma301-smmc-7721 mice lncrna expression profiles trans-blot nitrocellulose membrane esi-ft-icr-ms transforming growth factor article download pdf guangxi medical university scrambled sequence sir-nc full-length lnc-ma301 lnc-ma301 inhibited neoplasia enzyme-linked immunosorbent assay pl-lnc-ma301-smmc-7721 akt/gsk3β signaling pathways quantitative real-time pcr mrna encodes lnc-ma301 long noncoding rnas pl-smmc-7721 hcc cells revealing protein-lncrna interaction pl-lnc-ma301 cells negative control sir-nc digoxin-labeled probe overnight rna-binding protein caprin-1 akt/erk1 signaling pathways distinct structural features lnc-ma301-rna pull relative lnc-ma301 expression related subjects long noncoding rna qrt-pcr analysis revealed e-cadherin promotes progression construct plcdh-lnc-ma301 low lnc-ma301 expression privacy choices/manage cookies ft-icr-ms rneasy® mini kit full access jun-jie liu lnc-ma301 inhibits

Questions {❓}

Tumor-associated macrophages in hepatocellular carcinoma: friend or foe?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway
         description:Epithelial–mesenchymal transition (EMT) promotes migration, invasion, and metastasis of hepatocellular carcinoma (HCC) cells. The molecular mechanisms behind EMT and metastasis in HCC remain unclear. Microarray analysis was used to identify lncRNAs expression during polarization of U937 macrophages from M2 to M1 phenotype. The expression of the identified lncRNA was compared between clinical samples of HCC tissues or adjacent normal tissues, as well as between HCC and normal liver cell lines. lnc-Ma301 was overexpressed or knocked-down in HCC cell lines, and the effects were assessed in vitro and in vivo. Interactions among lnc-Ma301 and its potential downstream targets caprin-1 were investigated in HCC cell lines. Effects of lnc-Ma301 over- and underexpression on the Akt/Erk1 signaling pathways were examined. Microarray analyses identified lnc-Ma301 as one of the most overexpressed long non-coding RNAs during polarization of U937 macrophages from M2 to M1 phenotype. Lnc-Ma301 showed lower expression in HCC tissues than in adjacent normal tissues, and lower expression was associated with worse prognosis. Activation of lnc-Ma301 inhibited cell proliferation, migration and EMT in HCC cell cultures, and it inhibited lung metastasis of HCC tumors in mice. Mechanistic studies suggested that lnc-Ma301 interacts with caprin-1 to inhibit HCC metastasis and EMT through Akt/Erk1 pathway. Lnc-Ma301 may help regulate onset and metastasis of HCC.
         datePublished:2021-08-10T00:00:00Z
         dateModified:2021-08-10T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12935-021-02133-1
         keywords:
            Hepatocellular carcinoma
            Long non-coding RNAs
            Cancer migration
            Epithelial–mesenchymal transition
            Metastasis
            Cancer Research
            Cell Biology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig8_HTML.png
         isPartOf:
            name:Cancer Cell International
            issn:
               1475-2867
            volumeNumber:21
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hong-Lin Luo
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Ministry of Education
                     address:
                        name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tao Luo
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun-Jie Liu
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Fei-Xiang Wu
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tao Bai
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chao Ou
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Clinical Laboratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jie Chen
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Le-Qun Li
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
                     name:Ministry of Education
                     address:
                        name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jian-Hong Zhong
               url:http://orcid.org/0000-0002-1494-6396
               affiliation:
                     name:Guangxi Medical University Cancer Hospital
                     address:
                        name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Macrophage polarization-associated lnc-Ma301 interacts with caprin-1 to inhibit hepatocellular carcinoma metastasis through the Akt/Erk1 pathway
      description:Epithelial–mesenchymal transition (EMT) promotes migration, invasion, and metastasis of hepatocellular carcinoma (HCC) cells. The molecular mechanisms behind EMT and metastasis in HCC remain unclear. Microarray analysis was used to identify lncRNAs expression during polarization of U937 macrophages from M2 to M1 phenotype. The expression of the identified lncRNA was compared between clinical samples of HCC tissues or adjacent normal tissues, as well as between HCC and normal liver cell lines. lnc-Ma301 was overexpressed or knocked-down in HCC cell lines, and the effects were assessed in vitro and in vivo. Interactions among lnc-Ma301 and its potential downstream targets caprin-1 were investigated in HCC cell lines. Effects of lnc-Ma301 over- and underexpression on the Akt/Erk1 signaling pathways were examined. Microarray analyses identified lnc-Ma301 as one of the most overexpressed long non-coding RNAs during polarization of U937 macrophages from M2 to M1 phenotype. Lnc-Ma301 showed lower expression in HCC tissues than in adjacent normal tissues, and lower expression was associated with worse prognosis. Activation of lnc-Ma301 inhibited cell proliferation, migration and EMT in HCC cell cultures, and it inhibited lung metastasis of HCC tumors in mice. Mechanistic studies suggested that lnc-Ma301 interacts with caprin-1 to inhibit HCC metastasis and EMT through Akt/Erk1 pathway. Lnc-Ma301 may help regulate onset and metastasis of HCC.
      datePublished:2021-08-10T00:00:00Z
      dateModified:2021-08-10T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12935-021-02133-1
      keywords:
         Hepatocellular carcinoma
         Long non-coding RNAs
         Cancer migration
         Epithelial–mesenchymal transition
         Metastasis
         Cancer Research
         Cell Biology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12935-021-02133-1/MediaObjects/12935_2021_2133_Fig8_HTML.png
      isPartOf:
         name:Cancer Cell International
         issn:
            1475-2867
         volumeNumber:21
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hong-Lin Luo
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Ministry of Education
                  address:
                     name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tao Luo
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun-Jie Liu
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Fei-Xiang Wu
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tao Bai
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chao Ou
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Clinical Laboratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jie Chen
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Le-Qun Li
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
                  name:Ministry of Education
                  address:
                     name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jian-Hong Zhong
            url:http://orcid.org/0000-0002-1494-6396
            affiliation:
                  name:Guangxi Medical University Cancer Hospital
                  address:
                     name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cancer Cell International
      issn:
         1475-2867
      volumeNumber:21
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Ministry of Education
      address:
         name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Clinical Laboratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
      name:Ministry of Education
      address:
         name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
         type:PostalAddress
      name:Guangxi Medical University Cancer Hospital
      address:
         name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hong-Lin Luo
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Ministry of Education
            address:
               name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Tao Luo
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jun-Jie Liu
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Fei-Xiang Wu
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Tao Bai
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Chao Ou
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Clinical Laboratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jie Chen
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Le-Qun Li
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
            name:Ministry of Education
            address:
               name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jian-Hong Zhong
      url:http://orcid.org/0000-0002-1494-6396
      affiliation:
            name:Guangxi Medical University Cancer Hospital
            address:
               name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Ultrasound, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Clinical Laboratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China
      name:Key Laboratory of High-Incidence Tumor Early Prevention and Treatment, Ministry of Education, Nanning, People’s Republic of China
      name:Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, People’s Republic of China

External Links {🔗}(132)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

4.78s.

LINK . SPRINGER . COM {}